RPRX
Royalty Pharma plc · Healthcare
EVP & Chairman, Partnering Christopher Hite sold $6.0M of Royalty Pharma plc
Sold$5,997,250
$59.97Price
100,000Shares
−21%Stake
What RPRX did after the filing
- The stock from Thu, Aug 20 open, $61.33
- −4.7%
- S&P 500, same days
- −1.6%
18 of 30 trading days so far, to the Sep 16 close.
Traded Tue, Aug 18. Filed Wed, Aug 19, 4:20 PM ET, after the close. Returns use the Aug 20 open and the Sep 16 close. Not investment advice.